The ASHG president offers some meeting highlights and what she will be looking forward to next week in Boston.

During GEN's State of Biotech virtual summit, George Church, PhD, shared his thoughts on genomics and much, much more.

Developing cardiac inflammatory organoid models incorporating multiple cell lineages is vital for novel therapies.

Researchers in China have determined to identify the genetic basis for the naked mole-rats’ increased longevity.

Programmable proteins designed with Boolean logic gates may improve targeted drug delivery precision and scalability, researchers report.

The super adjuvant vaccine also protected against the spread of cancer to the lungs. When exposed to melanoma cells systemically, which mimics how cancer metastasizes, none of the ...

Raubling, Germany-based Axplora, which focuses on small-molecule API manufacturing reports that its total investments ...

Izpisua Belmonte, PhD, Altos Labs, advocates a disease-agnostic approach, but first, he said, “we must understand the mechanism, something that is core to the cell.” ...

An international team composed of scientists mainly from Boston and Munich sought to define plasma proteomic signatures that systematically capture the burden of atherosclerosis.

Seven trailblazing scientists receive ASHG’s 2025 Professional Awards for contributions in human genetics, leadership, and mentorship.

A new study presents computational strategies to manipulate membrane protein folding and function for biotechnological applications.

Physics-based ML framework designs IDPs—biomolecules without fixed structures that underlie key functions and diseases such as Parkinson’s.